|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/439 | |
| A61K 31/46 | |||
| A61P 25/20 |
| (11) | Number of the document | 2945626 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13705591.9 |
| Date of filing the European patent application | 2013-01-15 | |
| (97) | Date of publication of the European application | 2015-11-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2013/050368 |
| Date | 2013-01-15 |
| (87) | Number | WO 2014/111751 |
| Date | 2014-07-24 |
| (72) |
FENDT, Markus, CH
FEUERBACH, Dominik, CH
GOMEZ-MANCILLA, Baltazar, CH
LOPEZ-LOPEZ, Cristina, CH
MCALLISTER, Kevin Hall, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF ALPHA 7 NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF NARCOLEPSY |
| USE OF ALPHA 7 NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF NARCOLEPSY |